Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of tumors from Olfactory neuroblastoma patients

ABSTRACT: The RNA from tumors of four olfactory neuroblastoma patients were studied to understand the molecular pathways perturbed in such tumors. The resulting up and down regulated genes were used to look for novel cellular pathways that are commonly perturbed in plfactory neuroblastoma

ORGANISM(S): Homo sapiens

PROVIDER: GSE102285 | GEO | 2017/08/05

SECONDARY ACCESSION(S): PRJNA397217

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Transcriptomic profiling of the normal mammalian olfactory mucosa and olfactory neuroblastoma

Project description:Characterizing olfactory neuroblastoma with respect to normal olfactory mucosal tissue and cell types

2022-05-05 | GSE166612 | GEO

Xenograft tumors of neuroblastoma cell lines

Project description:Xenograft tumors of neuroblastoma cell lines

| PRJNA515055 | ENA

Genotyping in Neuroblastoma Primary tumors

Project description:We performed genotyping of Neuroblastoma Primary tumors using Illumina HumanHap 550 - v1,v3,v3duo and 610 Quad genotyping beadchips.

2011-09-15 | GSE19385 | GEO

Effect of HIFU on Murine Neuroblastoma Tumors

Project description:Effect of HIFU on Murine Neuroblastoma Tumors

| PRJNA564594 | ENA

Gene expression data from primary neuroblastoma tumors

Project description:This dataset contains gene expression data from the NRC series (Neuroblastoma Research Consortium) for a total of 283 primary neuroblastoma tumors. All tumor samples are fully annotated including patient age at diagnosis, overall and progresison free survival and MYCN amplification status, enabling subgroup analysis, survival analysis and gene expression network analysis.

2018-07-02 | GSE85047 | GEO

Expression profiling in Neuroblastoma Primary tumors and Cell lines

Project description:Expression profiling in Neuroblastoma Primary tumors and Cell lines

2009-12-03 | GSE19274 | GEO

Oligonucleotide array CGH in high-risk neuroblastoma tumors

Project description:We performed array CGH in high-risk neuroblastoma tumors in order to compare genome aberrations with expression of small non-coding RNAs.

2008-12-31 | GSE14109 | GEO

Gene expression profile at single cell level of neuroblastoma tumors and their tumor microenvironment

Project description:Neuroblastoma (NBL) tumors are considered heterogeneous tumors. So far, little detailed information available on their immune environment. We used single cell RNA sequencing (scRNA-seq) to analyze the tumor microenvironment of neuroblastoma.

2023-12-22 | GSE218003 | GEO

Olfactory

Project description:Olfactory

| PRJNA701412 | ENA

Effect of HIFU on Murine Neuroblastoma Tumors

Project description:This study assess the role of HIFU on genetic change intratumorally post-treatment Immunotherapy promises unprecedented benefits to cancer patients. However, the majority of cancer types, including high-risk neuroblastoma remain immunologically unresponsive. High intensity focused ultrasound (HIFU) is a non-invasive technique that can mechanically fractionate tumors, transforming immunologically ‘‘cold’’ tumors into responsive ‘‘hot’’ tumors. We treated tumors with HIFU, and assessed systemic immune response using flow-cytometry, ELISA, and gene sequencing. In addition, we combined this treatment with αCTLA-4 and αPD-L1 to study its effect on the immune response and long-term survival. Combining HIFU with αCTLA-4 and αPD-L1 significantly enhances anti-tumor response, improving survival from 0 to 62.5%. HIFU alone causes upregulation of splenic and lymph node NK cells and circulating IL-2, IFN-Ɣ, and DAMPs, whereas immune regulators like CD4+Foxp3+, IL-10, and VEGF-A are significantly reduced. We also report significant abscopal effect following unilateral treatment of mice with large, established bilateral tumors using HIFU and checkpoint inhibitors compared to tumors treated with HIFU or checkpoint inhibitors alone (61.1% survival, p<0.0001). HIFU can effectively induce immune sensitization in a previously unresponsive murine neuroblastoma model, and promises a novel yet efficacious immuno-adjuvant modality to overcome therapeutic resistance.

2020-09-30 | GSE137124 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data